Sernova (SVA) Stock Price, News & Analysis

Company Overview

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Key Stats

• Today's Range: C$0.23 to C$0.25
• 50-Day Range: C$0.23 to C$0.27
• 52-Week Range: C$0.20 to C$0.77
• Volume: 96,152 shs
• Average Volume: 164,969 shs
• Market Capitalization: C$78.08 million
• P/E Ratio: N/A
• Dividend Yield: 7.86%
• Price Target: C$1.83
• Consensus Rating: Buy

SVA Stock Analysis - Frequently Asked Questions

How have SVA shares performed this year?

Sernova's stock was trading at C$0.70 at the beginning of 2024. Since then, SVA shares have decreased by 65.7% and is now trading at C$0.24.
View the best growth stocks for 2024 here.

How were Sernova's earnings last quarter?

Sernova Corp. (TSE:SVA) issued its quarterly earnings results on Monday, September, 16th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.01.

How do I buy shares of Sernova?

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Sernova own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include ARC Resources (ARX), Meta Platforms (META), Newron Pharmaceuticals (NWPHF), Sernova (SEOVF), AMC Entertainment (AMC), Advanced Micro Devices (AMD) and CloudMD Software & Services (DOC).

Company Calendar

• Last Earnings: 9/16/2024
• Today: 11/21/2024
• Next Earnings (Estimated): 2/03/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: TSE:SVA
• CUSIP: N/A
• CIK: N/A
• Web: www.sinovacbio.com
• Phone: 861082890088
• Fax: N/A
• Employees: 1,959
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$1.83
• High Stock Price Target: C$2.50
• Low Stock Price Target: C$1.50
• Potential Upside/Downside: +663.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.13)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-38,930,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -726.29%
• Return on Assets: -119.26%

Debt

• Debt-to-Equity Ratio: 16.55
• Current Ratio: 0.32
• Quick Ratio: 18.11

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.04 per share
• Price / Cash Flow: 6.15
• Book Value: C($0.04) per share
• Price / Book: -6.00

Miscellaneous

• Outstanding Shares: 325,320,000
• Free Float: N/A
• Market Cap: C$78.08 million
• Optionable: Not Optionable
• Beta: 1.35